The US Food and Drug Administration (FDA) has withdrawn its emergency use authorization (EUA) for two drugs -- hydroxychloroquine and chloroquine -- to treat hospitalized Covid-19 patients, saying that they are unlikely to be effective and could carry potential risks.
It is no longer reasonable to believe that oral formulations of HCQ (hydroxychloroquine) and CQ (chloroquine) may be effective in treating Covid-19. Further, in light of ongoing reports of serious cardiac adverse events and several newly reported cases of methemoglobinemia in Covid-19 patients, the agency has concluded that the known and potential benefits of CQ and HCQ do not outweigh the known and potential risks for the authorized uses. Accordingly, FDA revokes the EUA for emergency use of HCQ and CQ to treat Covid-19. As of the date of this letter, the oral formulations of HCQ and CQ are no longer authorized by FDA to treat Covid-19, said the agency in a statement.
US President Donald Trump has been hyping hydroxychloroquine as a potential therapy against coronavirus which has not been approved. When questioned about the decision, Trump said, I took it and I felt good about taking it. I dont know if it had an impact, but it certainly didnt hurt me. I feel good. On March 28, 2020, the FDA approved the emergency use of oral formulations of chloroquine phosphate and hydroxychloroquine sulfate for the treatment of coronavirus patients. According to the FDA, based on information available to the agency at the time, it determined that CQ and HCQ may be effective in treating Covid-19. The agency had limited the use of the authorized products to adults and adolescents who weigh 50 kg or more and are hospitalized with Covid-19 when participation in a clinical trial is not available, or participation is not feasible. The FDA also subsequently cautioned against the use of hydroxychloroquine or chloroquine for Covid-19 outside of the hospital setting or a clinical trial due to the risk of heart rhythm problems.
Emerging data and published literature have raised new questions on whether CQ and HCQ may be effective in treating Covid-19 and whether CQ and HCQs known and potential benefits outweigh the known and potential risks associated with their authorized use. As part of the agencys ongoing review of the appropriateness of the EUA, FDA scientific staff conducted reviews of these new data and also conducted new analyses of information known at the time of initial authorization, it says.
According to the analysis, the FDA says that the suggested dosing regimens for CQ and HCQ are unlikely to produce an antiviral effect. The FDA also said that as of May 6, there were 347 adverse events in Covid-19 patients taking hydroxychloroquine and 38 in those taking chloroquine. The majority of cases, 69%, involved men with a median age in the early 60s. Five cases reported HCQ use through the EUA. The review states that there were 109 cases with serious cardiac episodes, including 80 cases of a serious heart rhythm disorder called QT prolongation. Other patients had different rhythm abnormalities, and 25 of the 109 died. There were also serious adverse events not affecting the heart in 113 cases, including liver abnormalities.
The agencys review further says that recent data from a large randomized controlled trial showed no evidence of benefit for mortality or other outcomes such as hospital length of stay or need for mechanical ventilation of HCQ treatment in hospitalized patients with the new coronavirus. Earlier reports of decreased viral shedding with CQ or HCQ treatment have not been consistently replicated and recent data from a randomized controlled trial assessing the probability of negative conversion showed no difference between HCQ and standard of care alone, says the FDA. In a separate statement, the FDA also warned that hydroxychloroquine should not be used with remdesivir for treating coronavirus patients as it may weaken the effectiveness of remdesivir. Following an evaluation, the FDA issued had an emergency use authorization in May 2020 allowing for remdesivir to be distributed in the US and to be administered intravenously by healthcare providers, as appropriate, to treat suspected or laboratory-confirmed Covid-19 in adults and pediatric patients hospitalized with severe disease.
The FDA is warning healthcare providers about a newly discovered potential drug interaction related to the investigational antiviral drug remdesivir, which has received emergency use authorization for the treatment of hospitalized Covid-19 patients with severe disease, said the agency. Based on a recently completed non-clinical laboratory study, the FDA is revising the fact sheet for healthcare providers that accompanies the drug to state that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir. The agency is not aware of instances of this reduced activity occurring in the clinical setting but is continuing to evaluate all data related to remdesivir, the statement cautioned.
- Frequency of Cardiac Rhythm Abnormalities in a Half ... - July 11th, 2018 [July 11th, 2018]
- Heart Arrhythmia - Arizona Heart Rhythm Center - November 20th, 2018 [November 20th, 2018]
- Cardiac Abnormalities Associated With Charcot-Marie-Tooth ... - December 8th, 2018 [December 8th, 2018]
- Troponin - Wikipedia - December 20th, 2018 [December 20th, 2018]
- Heart - Wikipedia - December 20th, 2018 [December 20th, 2018]
- Implantable Cardiac Defibrillators (Implantable ... - January 23rd, 2019 [January 23rd, 2019]
- Cardiac Rhythm - Coverage | Medtronic - January 23rd, 2019 [January 23rd, 2019]
- Overview of Abnormal Heart Rhythms - Heart and Blood ... - March 2nd, 2019 [March 2nd, 2019]
- Inherited Heart Rhythm Clinic | LHSC - March 8th, 2019 [March 8th, 2019]
- Procedures - Arizona Heart Rhythm Center - April 24th, 2019 [April 24th, 2019]
- Sudden death in young people: Heart problems often blamed ... - April 29th, 2019 [April 29th, 2019]
- abnormalities of cardiac conduction and cardiac rhythm ... - September 11th, 2019 [September 11th, 2019]
- Who is at risk for atrial fibrillation, or AFib, and why does it matter? - Yahoo Lifestyle - October 9th, 2019 [October 9th, 2019]
- Sanders Said He Had a Common Heart Procedure. So Why the Mystery? - The New York Times - October 9th, 2019 [October 9th, 2019]
- Media Advisory - Canadian Cardiovascular Congress gathers leading heart experts in Montreal to discuss latest research innovations - Canada NewsWire - October 24th, 2019 [October 24th, 2019]
- Why Did the Young Mother Have Searing Head Pain and a Racing Heart? - The New York Times - November 2nd, 2019 [November 2nd, 2019]
- Student Heart check scheduled for Dec. 14 at Fordson High School - Dearborn Press and Guide - November 22nd, 2019 [November 22nd, 2019]
- Neurometrix (NASDAQ:NURO) and Boston Scientific (NASDAQ:BSX) Head to Head Contrast - Riverton Roll - December 22nd, 2019 [December 22nd, 2019]
- Ask the Expert: What is ventricular tachycardia, and what treatment options are available? - The Daily Progress - December 22nd, 2019 [December 22nd, 2019]
- Beyond the Byline: Who really did steal the kishka? - Wilkes Barre Times-Leader - December 31st, 2019 [December 31st, 2019]
- Local leaders offer their Happy New Year wishes - Wilkes Barre Times-Leader - December 31st, 2019 [December 31st, 2019]
- Cardiologs raises $15m in Aleven-led Series A funding round - Medical Device Network - January 10th, 2020 [January 10th, 2020]
- Marion County Schools working to be "Heart Safe" certified - WDTV - January 10th, 2020 [January 10th, 2020]
- The Dangers of Weight Loss Supplements and Why You Should Avoid Them - One Green Planet - February 15th, 2020 [February 15th, 2020]
- Amish kids were dying mysteriously. Mayo scientists solved it. But can they treat it? - Minnesota Public Radio News - February 20th, 2020 [February 20th, 2020]
- UI doctors discover new genetic mutation that causes fatal heart arrhythmias - UI The Daily Iowan - February 22nd, 2020 [February 22nd, 2020]
- Here's Why You Shouldn't Worry About Apple Watch AFib Detection - The Mac Observer - February 27th, 2020 [February 27th, 2020]
- Team deciphers how myotonic dystrophy generates lethal heart dysfunctions - University of Illinois News - February 27th, 2020 [February 27th, 2020]
- Cardiac injury in COVID-19 patients linked with higher death rate - Cardiac Rhythm News - March 26th, 2020 [March 26th, 2020]
- Electrophysiology Market: Global Industry Valuation 2020| In Depth Analysis, Solution, Industry Influence By 2028 - Cole of Duty - May 23rd, 2020 [May 23rd, 2020]
- What you need to know about hydroxychloroquine - WTSP.com - May 23rd, 2020 [May 23rd, 2020]
- Malaria Drug Taken by Trump Is Tied to Increased Risk of Heart Problems and Death in New Study - The New York Times - May 23rd, 2020 [May 23rd, 2020]
- Research by Huami Shows Smart Wearable Device Big Data could assist with alerting new trends related to COVID-19 - Devdiscourse - May 24th, 2020 [May 24th, 2020]
- Dealing With Electrolyte Imbalances Including The Use Of Sports Drinks - Teton Gravity Research - May 28th, 2020 [May 28th, 2020]
- Abnormal EKG: What It Means and Treatment Options - May 28th, 2020 [May 28th, 2020]
- Abnormal Heart Rhythms: Types, Causes, Diagnosis, Treatment - May 28th, 2020 [May 28th, 2020]
- Electrophysiology Market: Global Industry Valuation 2020| In Depth Analysis, Solution, Industry Influence By 2028 - 3rd Watch News - June 18th, 2020 [June 18th, 2020]
- Critically ill patients with COVID-19 at risk to develop heart rhythm disorders - Penn: Office of University Communications - June 29th, 2020 [June 29th, 2020]
- COVID-19 Patients in ICU 10 Times More Likely to Experience Heart Rhythm Disorders, Finds Study - HospiMedica - July 5th, 2020 [July 5th, 2020]
- Doctors Seeing Heart Inflammation In Young People With Coronavirus: Are These People At Risk? - CBS Pittsburgh - August 14th, 2020 [August 14th, 2020]
- EMS Treatment of Hyperkalemia - EMSWorld - September 7th, 2020 [September 7th, 2020]
- The virus and other diseases - The Indian Express - September 8th, 2020 [September 8th, 2020]
- Cardiac arrhythmia and COVID-19: Here are answers to some frequently-asked questions - The Indian Express - September 8th, 2020 [September 8th, 2020]
- COVID-19 and its effects on heart disease: How to create a system to safeguard patients during pandemic - Times Now - September 8th, 2020 [September 8th, 2020]
- The Wireless Ambulatory Telemetry Monitors market to ramify in unexplored territories in the next decade - KYT24 - October 23rd, 2020 [October 23rd, 2020]
- Health Pro: Cardiologist passionate about keeping your heart ticking - Florida Today - October 23rd, 2020 [October 23rd, 2020]
- What We Know About COVID-19 and Long-Term Heart Damage - Healthline - October 23rd, 2020 [October 23rd, 2020]
- COVID-19 can affect the heart - Science Magazine - October 23rd, 2020 [October 23rd, 2020]
- Researchers discover more effective treatment option for heart condition - OSU - The Lantern - October 23rd, 2020 [October 23rd, 2020]
- From breathlessness to brain fog, Indian doctors are now up against effects of long COVID - Firstpost - November 1st, 2020 [November 1st, 2020]
- Heart of the issue - The New Indian Express - December 8th, 2020 [December 8th, 2020]
- CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021 - GlobeNewswire - December 28th, 2020 [December 28th, 2020]
- [Full text] Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance | TACG - Dove Medical Press - January 30th, 2021 [January 30th, 2021]
- Temporary Cardiac Pacing Wires & Leads Market Promising Growth Opportunities and Forecast 2018-2028 NeighborWebSJ - NeighborWebSJ - January 30th, 2021 [January 30th, 2021]
- Temporary Cardiac Pacing Leads Market Incredible Possibilities, Growth Analysis and Forecast To 2025 NeighborWebSJ - NeighborWebSJ - January 30th, 2021 [January 30th, 2021]
- COVID-19 Impact: Wide range of new, returning, or ongoing health problems - Free Press Journal - July 4th, 2021 [July 4th, 2021]
- Post-recovery, many COVID-19 patients report breathlessness, rapid heartbeats or palpitations, says expert - The Hindu - October 5th, 2021 [October 5th, 2021]
- Coronavirus and how it affects a person's heart - Goshen News - October 5th, 2021 [October 5th, 2021]
- Hackensack University Medical Center Cardiac Researcher Presented New Data about the Heart and COVID-19 and Other Key Topics at Heart Rhythm Society... - October 5th, 2021 [October 5th, 2021]
- New $17M Heart Rhythm Center will be added to Baptist Heart Hospital - Ponte Vedra Recorder - October 13th, 2021 [October 13th, 2021]
- My healthy wife died as I lay next to her I was making a cup of tea when my daughter realised... - The Sun - October 13th, 2021 [October 13th, 2021]
- What We Know About Cardiac Long-COVID Two Years Into the Pandemic - Diagnostic and Interventional Cardiology - January 26th, 2022 [January 26th, 2022]
- Monkeypox and the Heart: Acute Myocarditis Rare, With Good Outlook - TCTMD - September 4th, 2022 [September 4th, 2022]
- A Broken Heart After Witnessing a Dying Heart: A Case of Takotsubo Cardiomyopathy - Cureus - September 4th, 2022 [September 4th, 2022]